Weakness reported in FDA approval system for new cardiovascular devices HERE.
The drug approval path has always had such weaknesses, as well. Indeed it would be cost-prohibitive to conduct and await truly strong scientific analyses/screens of products in the medical pipeline. The pressure to opt for speed (and profit) in the process will always overwhelm the emphasis on safety. The solution is
Popular Posts
-
Biology concepts – hydrogenosome, FeS cluster protein, loricifera, erythrocyte More than one way to skin a cat seems to be a newer versi... -
Lab Times is a magazine that reports on news for life scientists in Europe. Their current issue (Sept. 14, 2011) has an "analysis... -
Here's a video of my talk at Eschaton 2012 in Ottawa (Dec. 1, 2012).
-
As someone interested in linguistic recursion, I gotta join in... the below blog post has been getting a fair amount of attention around the...
-
My next door neighbor used to be the chair of the Immunology Department but Immunology recently moved to another floor of this building. The... -
Biology Concepts – pollen, plastid inheritance, gymnosperms, angiosperms I am coming to believe that plants are more complex than animals, e... -
Biology concepts – fever, infectious disease, sexually transmitted disease, innate immune system Would you be willing to be a human guinea... -
I met many interesting people at Eschaton 2012 in Ottawa. One of them was Ian Cromwell who gave a talk about racism on Sunday morning. Ian ... -
I claim that the top three criteria for good science reporting are: Accuracy, Accuracy, and Accuracy. Everything else falls into fourth plac... -
Many proteins bind to double-stranded DNA and most of them bind specifically to a particular target site. The lac repressor, for example, b...
